Skip to content

Dr. Pascale Abrams

Active Private limited companyfounded 2008active for 18 yearsBoechoutselei 55, 2640 MortselKBO/BCE: BE 0896.314.147 #6 company by total assets in Mortsel, Health and social work sector

Lifetime

17 annual accounts with figures on one time axis
peak of €1.2m in 2025
€1.2m▲ 18.4%
peak of €726,487 in 2025
€726,487▲ 17.8%
peak of €3.9m in 2025
€3.9m▲ 11.4%
€1.0m▲ 18.3%
peak of 0.3 FTE in 2014
-not published
Board1 name since 2021
1 director
Documentsfilings and deeds
24-11-202524 days late
2025abbreviated format
Gross margin from €981,587 to €1.2mAmendment of the articles 03-03Dividend €332,610Debts from €864,851 to €1.0mCash from €450,913 to €815,860

Key points

from the 2025 annual accounts

Equity

€3.9m ▲ 11.4%

Dr. Pascale Abrams has made a profit in every financial year since 2008.

Filings

17 annual accounts 21 days past the deadline
deadline2010201520202025

2026 accounts not filed: deadline was 31-10-2026.

Position in the sector

€726,487

Higher net result than 95% of companies in human health. The sector median is €124,849, over 2,783 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as Dr. Pascale Abrams has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for Dr. Pascale Abrams. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0896314147
Amendment of the articles General meeting of 21-01-2025 · Gazette deed
changes role from manager to director Discharge granted to · General meeting of 15-03-2021 · Gazette deed
Capital decrease of €262,400 to €18,600 The capital fell from €281,000 to €18,600 · Gazette deed
All 32 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Pascale Abrams Mortsel €4.9m €1.2m 79.1% -
Dokter Gregory Haverbeke Kontich €4.6m €1.1m 60.2% 0.8
ST27 Brussels €5.2m €1.2m 45.3% 2
DR. SCHEPERS Genk €5.0m €1.2m 98.0% -
Dr. F. Thiessen Mortsel €3.6m €1.1m 66.2% -
DR SEBASTIEN ONGENA - MKA CHIRURG Schilde €5.9m €1.0m 43.1% -
Dr. W. Peeters Brasschaat €6.5m €1.3m 82.8% 1.6

These companies have the same main activity as Dr. Pascale Abrams: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €3.6m and €6.5m, founded between 2005 and 2011.

Official details

Source: KBO
Status
Active since 10-03-2008Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Establishment unit
2.214.374.1012640 Mortsel, registered on 10-03-2008
Financial year end
31 March
Peppol
Reachable since 28-11-2025
Company details

Annual accounts to 31-03-2025

≈ €970,000estimated
€4.9m▲ 12.7%
Filing
Filed on 24-11-2025
Financials

Insights on Dr. Pascale Abrams

Dr. Pascale Abrams files the abbreviated format. That format states no turnover. The gross margin rose from €108,551 in 2008 to €1.2m in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Pascale Abrams

What is the company number of Dr. Pascale Abrams?
The company number of Dr. Pascale Abrams is 0896.314.147. The VAT number is the same number with BE in front: BE 0896.314.147.
Where is Dr. Pascale Abrams based?
The registered office is at Boechoutselei 55, 2640 Mortsel.Company details
What does Dr. Pascale Abrams do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Pascale Abrams?
Dr. Pascale Abrams is a private limited company (BV).
When was Dr. Pascale Abrams founded?
Dr. Pascale Abrams was founded on 10-03-2008.
Is Dr. Pascale Abrams still active?
Yes, Dr. Pascale Abrams is an active enterprise in the KBO register.
How many employees does Dr. Pascale Abrams have?
Dr. Pascale Abrams had an average of 0.2 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of Dr. Pascale Abrams?
The turnover in financial year 2025 is about €970,000. This figure is estimated from the gross margin of €1.2m and 30 comparable companies (NACE 862). It probably lies between €920,000 and €1.3m.
Is Dr. Pascale Abrams profitable?
In financial year 2025, Dr. Pascale Abrams made a profit of €726,487.
Where can I find the annual accounts of Dr. Pascale Abrams?
Dr. Pascale Abrams filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Pascale Abrams due?
Dr. Pascale Abrams had to file the annual accounts for financial year 2026 by 31-10-2026.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.